Why the study?
Stroke remains a leading cause of death and disability, making it essential to weigh the benefits of neuroprotective drugs like glibenclamide against their safety.
Does glibenclamide improve survival and reduce disability in patients who had a stroke?
Does glibenclamide improve survival and reduce disability in patients who had a stroke?
No takes yet. Share an insight, caveat, or question.
This protocol outlines a planned systematic review and meta-analysis to assess the neuroprotective benefits and safety of glibenclamide in stroke patients.
Wen et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: